Solvias AG, headquartered in Switzerland (CH), is a leading provider of analytical and development services in the pharmaceutical and biotechnology sectors. Founded in 1998, the company has established itself as a trusted partner for clients seeking high-quality solutions in drug development, quality control, and regulatory compliance. With a strong presence in Europe and North America, Solvias offers a comprehensive range of services, including method development, validation, and stability studies. Their unique approach combines scientific expertise with state-of-the-art technology, ensuring precise and reliable results tailored to client needs. Recognised for its commitment to excellence, Solvias has achieved significant milestones, including numerous successful collaborations with major pharmaceutical companies. This positions them as a key player in the industry, dedicated to advancing drug development and ensuring the highest standards of quality.
How does Solvias's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Solvias's score of 18 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Solvias reported no carbon emissions, with a total of 0 kg CO2e across all scopes, including Scope 1, 2, and 3. This data indicates a commitment to minimising their carbon footprint, although specific reduction targets or initiatives have not been disclosed. Solvias has not inherited any emissions data from a parent company, and there are no reported climate pledges or SBTi targets. The company has received a strong assessment from EcoVadis, reflecting its commitment to sustainability practices. As Solvias continues to develop its climate strategy, further transparency regarding future emissions and reduction initiatives will be essential for stakeholders.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Solvias has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
